Company intelligence / Profile preview

SBH Sciences

Natick, Massachusetts, United Statessbhsciences.com ↗

Ownership: Private
Development stage: Commercial

Overview

SBH Sciences is a leading preclinical CRO specializing in cell-based assays for cytokine and growth factor activity. It offers recombinant proteins/enzymes/antibodies production and custom bioassay development. The company has supported the development of seven new chemical entities including one approved drug but does not have its own clinical pipeline.

Therapeutic areas: OncologyCardiovascularImmunologyNeurology
Modalities: Recombinant proteinMonoclonal antibodyEnzyme replacement therapySmall moleculePeptides
Industry: Drug Discovery Services

Partnerships

Woodland Pharmaceuticals/Woodland Biosciencesover 300 biotech companies globally for contract services

Beyond the preview

Go deeper on SBH Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBH Sciences.

Explore the full profile